NOVABRIDGE BIOSCIENCES (NBP) Stock Balance Sheet
USA - NASDAQ:NBP - US44975P1030 - ADR
4.29 USD
+0.29 (+7.25%)
4.28 USD
-0.01 (-0.23%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | null | null | 2.14B | 3.21B | 3.52B | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | 143.22M | 235.40M | 753.20M | |||
| Receivables | null | 1.04M | 1.79M | 8.20M | 376.40M | |||
| Inventories | null | null | null | 0 | 27.20M | |||
| Other Current Assets | 2.03M | 2.25M | 16.67M | 168.80M | 101.30M | |||
| Total Current Assets | 168.00M | 177.00M | 330.00M | 3.63B | 4.78B | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.38M | 3.80M | 5.55M | 124.00M | 158.50M | |||
| Investments And Advances | 34.00M | 31.00M | 12.08M | 30.90M | 352.10M | |||
| Goodwill | null | null | 0 | 162.60M | 162.60M | |||
| Intangibles | null | null | 118.11M | 118.90M | 119.70M | |||
| Other Non-Current Assets | 1.22M | 1.37M | 250.00K | 10.90M | 26.60M | |||
| Total Non-Current Assets | 39.00M | 36.00M | 39.00M | 447.20M | 819.50M | |||
| TOTAL ASSETS | 207.00M | 213.00M | 369.00M | 4.07B | 5.60B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 19.00M | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 850.00K | 8.35M | 7.20M | 724.10M | 564.30M | |||
| Accounts Payable | null | null | 357.75M | null | 57.40M | |||
| Other Current Liabilities | null | 110.00K | 51.00M | 15.10M | 2.40M | |||
| Total Current Liabilities | 7.35M | 8.45M | 58.00M | 758.20M | 624.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 2.63M | 3.07M | 68.00M | 405.60M | 417.60M | |||
| Total Non-Current Liabilities | 2.63M | 3.55M | 68.00M | 405.60M | 417.60M | |||
| TOTAL LIABILITIES | 9.98M | 12.00M | 126.00M | 1.16B | 1.04B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.29B | -1.29B | -1.26B | -6.86B | -4.35B | |||
| Additional Paid In Capital | 1.46B | 1.46B | 1.48B | 9.58B | 9.10B | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 20.00K | 20.00K | 20.00K | 100.00K | 100.00K | |||
| Treasury Stock | -5.61M | -6.23M | -8.01M | -21.20M | null | |||
| Other Shareholders' Equity | 37.00M | 33.00M | 40.00M | 213.80M | -186.50M | |||
| Shares Outstanding | 115.27M | 114.65M | 114.04M | 117.04M | 112.69M | |||
| Tangible Book Value per Share | null | null | 0.6715 | 13.7685 | 23.2715 | |||
| Total Shareholders' Equity | 197.00M | 201.00M | 243.00M | 2.91B | 4.56B | |||
| TOTAL LIABILITIES AND EQUITY | 207.00M | 213.00M | 369.00M | 4.07B | 5.60B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 22.86 | 20.95 | 5.69 | 4.78 | 7.66 | |||
| Return On Assets (ROA) | -18.22% | -10.33% | -56.37% | -61.55% | -41.63% | |||
| Return On Equity (ROE) | -19.14% | -10.95% | -85.60% | -86.16% | -51.13% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21